Boston Biomedica, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Assets of wholly owned esoteric clinical reference lab subsidiary BBI Clinical Labs are purchased by Specialty Labs of Santa Monica, California for $9.5 mil. cash. The deal, announced Feb. 20, adds BBICL's expertise in Lyme disease and tick-borne pathogens and immunological/molecular analysis of HIV and viral hepatitis to Specialty's more than 3,500 clinical reference lab test offerings. Transaction includes transitional services agreement under which Bridgewater, Massachusetts-based BBI will support the integration of the divested unit over the remainder of 2001